Iwasa Z, Matsumoto K, Yamato M, Yasutomi M
Jpn J Surg. 1985 May;15(3):195-9. doi: 10.1007/BF02469886.
The estrogen receptors (ER) in breast cancer tissues were investigated in 122 patients using an immunoperoxidase method. ER (+) were evident in 77 of 122 patients (63.1 per cent). If classified according to pre- and postmenopausal subjects. ER (+) was seen in 61.4 per cent and ER (-) in 32.9 per cent before menopause, and ER (+) in 65.4 per cent and ER (-) in 30.8 per cent after menopause with no marked difference between the two. If classified according to histological type, ER (+) was seen in 72.3 per cent of those with papillotubular carcinoma and in 62.0 per cent of those with scirrhous carcinoma, whereas ER (-) was seen in 44.9 per cent of those with medullary tubular carcinoma. ER (+) was seen in carcinoma with apocrine metaplasia, lobular carcinoma and Paget's carcinoma. Concerning the relationship between primary tumors and metastatic lymph nodes, ER (+) for both was seen in 20 of 41 patients (48.8 per cent) whereas ER (-) for both was found in 9 of 41 patients (22.0 per cent). Four patients with local recurrences had a positive ER (+) at the beginning of treatment, but the ER became negative after hormonal treatment and chemotherapy.
采用免疫过氧化物酶法对122例乳腺癌组织中的雌激素受体(ER)进行了研究。122例患者中有77例(63.1%)ER呈阳性。若按绝经前和绝经后患者分类,绝经前ER(+)占61.4%,ER(-)占32.9%;绝经后ER(+)占65.4%,ER(-)占30.8%,两者之间无明显差异。若按组织学类型分类,乳头管状癌患者中72.3% ER呈阳性,硬癌患者中62.0% ER呈阳性,而髓样管状癌患者中44.9% ER呈阴性。大汗腺化生癌、小叶癌和派杰氏癌中可见ER(+)。关于原发肿瘤与转移淋巴结的关系,41例患者中有20例(48.8%)两者ER均为阳性,而41例患者中有9例(22.0%)两者ER均为阴性。4例局部复发患者在治疗开始时ER(+)呈阳性,但在激素治疗和化疗后ER转为阴性。